loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Abbott India Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Abbott India Ltd. 13 Aug 2026 11:18 AM

Q1FY27 Quarterly Result Announced for Abbott India Ltd.

Pharmaceuticals company Abbott India announced Q1FY27 results

Financial Highlights:

  • Revenue from Operations: For Q1FY27, the company reported revenue of Rs 1,813.68 crore, representing a YoY increase of 4.33% from Rs 1,738.35 crore in Q1FY26 and a QoQ growth of 6.09% from Rs 1,709.51 crore in Q4FY26.
  • Total Income: The total income for Q1FY27 stood at Rs 1,889.05 crore, a YoY growth of 4.30% compared to Rs 1,811.19 crore in Q1FY26 and a QoQ increase of 5.82% compared to Rs 1,785.10 crore in Q4FY26.
  • Profit Before Tax (PBT): PBT reached Rs 572.21 crore in Q1FY27, up by 16.04% YoY from Rs 493.13 crore in Q1FY26. On a QoQ basis, PBT increased by 7.72% from Rs 531.23 crore in Q4FY26.
  • Net Profit for the Period: The company recorded a net profit of Rs 428.52 crore in Q1FY27, marking a YoY increase of 17.13% from Rs 365.86 crore in Q1FY26 and a QoQ increase of 8.51% from Rs 394.93 crore in Q4FY26.
  • Total Comprehensive Income: This stood at Rs 428.56 crore in Q1FY27, compared to Rs 365.90 crore in Q1FY26 and Rs 396.66 crore in Q4FY26.
  • Other Income: For Q1FY27, other income was Rs 75.37 crore, compared to Rs 72.84 crore in Q1FY26.
  • Earnings Per Share (EPS): Basic and diluted EPS for Q1FY27 was Rs 201.66, compared to Rs 172.17 in Q1FY26 and Rs 185.85 in Q4FY26.

Result PDF

Pharmaceuticals company Abbott India announced Q4FY26 & FY26 results

Q4FY26 Financial Highlights:

  • Revenue from Operations: Stood at Rs 1,709.51 crore in Q4FY26, registering a YoY increase of 6.54% compared to Rs 1,604.59 crore in Q4FY25, and a QoQ slight decline of 0.84% from Rs 1,724.04 crore in Q3FY26.
  • Total Income: Reported at Rs 1,785.10 crore in Q4FY26, showing a YoY growth of 6.22% from Rs 1,680.61 crore in Q4FY25, and a QoQ decrease of 0.48% from Rs 1,793.80 crore in Q3FY26.
  • Profit Before Tax (PBT): Reached Rs 531.23 crore in Q4FY26, reflecting a YoY growth of 10.05% against Rs 482.71 crore in Q4FY25, and a QoQ increase of 4.37% compared to Rs 508.98 crore in Q3FY26.
  • Profit for the Period (PAT): Achieved Rs 394.93 crore in Q4FY26, up by 7.60% YoY from Rs 367.04 crore in Q4FY25, and growing 5.05% QoQ from Rs 375.96 crore in Q3FY26.
  • Total Comprehensive Income: Stood at Rs 396.66 crore in Q4FY26, up from Rs 361.60 crore in Q4FY25 and Rs 373.31 crore in Q3FY26.
  • Earnings Per Share (EPS): Basic and Diluted EPS for Q4FY26 was Rs 185.85, an increase from Rs 172.72 in Q4FY25 and Rs 176.92 in Q3FY26.

FY26 Financial Highlights:

  • Revenue from Operations: Increased to Rs 6,929.05 crore in FY26, marking a YoY growth of 8.11% from Rs 6,409.15 crore in FY25.
  • Total Income: Jumped to Rs 7,217.19 crore in FY26, representing a YoY growth of 7.96% compared to Rs 6,684.73 crore in FY25.
  • Profit Before Tax (PBT): Grew to Rs 2,079.27 crore in FY26, up by 10.19% YoY from Rs 1,886.95 crore in FY25.
  • Profit for the Year (PAT): Reported at Rs 1,552.02 crore in FY26, indicating a YoY increase of 9.73% against Rs 1,414.44 crore in FY25.
  • Total Comprehensive Income: Achieved Rs 1,551.17 crore in FY26, growing from Rs 1,409.02 crore in FY25.
  • Earnings Per Share (EPS): Basic and Diluted EPS for the full year FY26 was Rs 730.36, compared to Rs 665.62 in FY25.
  • Dividend: The Board of Directors recommended a final dividend of Rs 525 and a special dividend of Rs 131 per equity share of Rs 10 each for FY26.

Result PDF

Pharmaceuticals company Abbott India announced Q3FY26 results

  • Revenue: Rs 1,724.04 crore against Rs 1,614.28 crore during Q3FY25, change 7%.
  • PBT: Rs 508.98 crore against Rs 487.59 crore during Q3FY25, change 4%.
  • PAT: Rs 375.96 crore against Rs 360.78 crore during Q3FY25, change 4%.
  • EPS: Rs 176.92 for Q3FY26.

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Get it on google Play Store Download on the App Store
market app